Selective Inhibition of Nuclear Export (SINE) and Canine Osteosarcoma

Informed consent is a process that helps you learn about the research study. After learning about the study, you will be able to ask the researcher or his/her staff questions. You should only agree to take part after you clearly understand the study and feel comfortable. You should take time to talk over your decision with your doctors, family, and friends. If you agree to take part, you will be asked to sign an "informed consent form."

• You have the right to not take part in a research study.
• You have the right to drop out at anytime.
• You have the right to be given new information about the study.
• You have the right to ask questions at any time and have them answered as soon as possible.
• You also have the responsibility to stay informed during your participation in a study. You should ask questions about anything you do not understand or simply want to know.

You may consider having your pet participate in a study because:

• They may benefit from the best possible treatment or an experimental treatment that would otherwise not be available.
• The veterinarians and technicians will closely monitor your pet’s progress throughout the trial.
• You would be helping researchers to improve the treatments for future patients.

You might consider not taking part in a study because:

• The experimental treatment may not work for your pet, or it could make your condition worse.
• The experimental treatment may cause side effects that no one anticipated.
• If the trial is randomized and includes a placebo (an inactive, dummy pill), your pet may not be given the experimental treatment.
• The amount of testing for efficacy and safety purposes may involve too many trips to the research office and take too much time.

There is no guarantee that a clinical trial will help your pet’s condition, but the results will contribute to knowledge that may make a difference in the future care of patients.

• If my pet is ill, will this research help them?
• What are the risks?
• What is involved? What will I have to do?
• Will I be charged anything or compensated for my participation?
• How can I end my participation if I change my mind?
• What will happen when the study is over? Will I be told the results?
• Is the study controversial?
• Whom do I contact to express concerns or obtain information?

Clinical trials test new drugs, devices, or treatments. In some cases, taking part will not cost you anything. In other studies, the research team may bill you for drugs, devices, and services they provide. The study informed consent form will describe any costs to you in detail. If the information in the consent form is not clear, you should ask the research team to explain any costs before you sign the consent form.

Your pet is protected first and foremost by being told honestly and without bias what the known and potential risks are for participating in the trial. This information will be submitted to you in a language you will be able to understand. There is an Institutional Review Board (IRB) requirement that every participant in a clinical trial be informed about the possible risks, benefits and available alternatives. All of the information necessary to assist you in determining whether or not your pet should participate in a clinical trial is provided in a document called the "informed consent document." This document informs you of how to let the investigator know if you think your pet is experiencing a problem with the research and what resources are available to help you. You should ask any questions you may have about a clinical trial before signing the informed consent document. Even after you have signed the informed consent document to have your pet participate in a clinical trial, you should always speak to the investigator if you have questions or problems.

The Institutional Review Board (IRB) protects people and animals in research studies. The IRB includes scientists, non-scientists, and community members. The IRB reviews, approves, and monitors all in which pets take part. This oversight keeps risks to research participants as low as possible. The IRB also keeps track of ongoing studies to make sure they are being done in the right way.

This varies by study and will be covered in your Informed Consent Document.

Generally, participation ends when the study ends because it might not be safe or effective to continue treatment based on what is known at the time. Sometimes patients can remain on the study drug if they are responding to the new treatment; however, this is the exception rather than the rule.

Randomized is used to describe a research study that hopes to compare two or more different treatments or procedures. Randomized means that your pet will be assigned to a study group by chance, like flipping a coin.

Most randomized trials will only disclose this kind of information when the study has been completely finalized; this is done to protect the integrity of the research data and results. If the trial is a "double-blind" trial, the doctor will not even know which substance your pet received. Most protocols will have information with respect to when a study will be "unblinded." If this is something that you want to know more about, ask the investigator what the study's policy is before you agree to participate.